nodes	percent_of_prediction	percent_of_DWPC	metapath
Foscarnet—Injection site pain—Epirubicin—liver cancer	0.0042	0.0042	CcSEcCtD
Foscarnet—Rash erythematous—Doxorubicin—liver cancer	0.00415	0.00415	CcSEcCtD
Foscarnet—Fungal infection—Doxorubicin—liver cancer	0.00411	0.00411	CcSEcCtD
Foscarnet—Skin ulcer—Doxorubicin—liver cancer	0.00408	0.00408	CcSEcCtD
Foscarnet—Abscess—Doxorubicin—liver cancer	0.00401	0.00401	CcSEcCtD
Foscarnet—Rash pustular—Doxorubicin—liver cancer	0.00398	0.00398	CcSEcCtD
Foscarnet—Muscle spasms—Sorafenib—liver cancer	0.0039	0.0039	CcSEcCtD
Foscarnet—Rigors—Doxorubicin—liver cancer	0.00389	0.00389	CcSEcCtD
Foscarnet—Injection site pain—Doxorubicin—liver cancer	0.00389	0.00389	CcSEcCtD
Foscarnet—Rectal haemorrhage—Epirubicin—liver cancer	0.0038	0.0038	CcSEcCtD
Foscarnet—Skin discolouration—Epirubicin—liver cancer	0.0038	0.0038	CcSEcCtD
Foscarnet—Anaemia—Sorafenib—liver cancer	0.00375	0.00375	CcSEcCtD
Foscarnet—Hypocalcaemia—Epirubicin—liver cancer	0.00375	0.00375	CcSEcCtD
Foscarnet—Nocturia—Epirubicin—liver cancer	0.0037	0.0037	CcSEcCtD
Foscarnet—Leukopenia—Sorafenib—liver cancer	0.00363	0.00363	CcSEcCtD
Foscarnet—Cough—Sorafenib—liver cancer	0.00354	0.00354	CcSEcCtD
Foscarnet—Skin discolouration—Doxorubicin—liver cancer	0.00352	0.00352	CcSEcCtD
Foscarnet—Rectal haemorrhage—Doxorubicin—liver cancer	0.00352	0.00352	CcSEcCtD
Foscarnet—Hypertension—Sorafenib—liver cancer	0.0035	0.0035	CcSEcCtD
Foscarnet—Coordination abnormal—Epirubicin—liver cancer	0.00349	0.00349	CcSEcCtD
Foscarnet—Hypocalcaemia—Doxorubicin—liver cancer	0.00347	0.00347	CcSEcCtD
Foscarnet—Myalgia—Sorafenib—liver cancer	0.00346	0.00346	CcSEcCtD
Foscarnet—Arthralgia—Sorafenib—liver cancer	0.00346	0.00346	CcSEcCtD
Foscarnet—Phosphatase alkaline increased—Epirubicin—liver cancer	0.00343	0.00343	CcSEcCtD
Foscarnet—Nocturia—Doxorubicin—liver cancer	0.00342	0.00342	CcSEcCtD
Foscarnet—Dry mouth—Sorafenib—liver cancer	0.00338	0.00338	CcSEcCtD
Foscarnet—Melaena—Epirubicin—liver cancer	0.00335	0.00335	CcSEcCtD
Foscarnet—Influenza like illness—Epirubicin—liver cancer	0.00333	0.00333	CcSEcCtD
Foscarnet—Infection—Sorafenib—liver cancer	0.00329	0.00329	CcSEcCtD
Foscarnet—Candida infection—Epirubicin—liver cancer	0.00328	0.00328	CcSEcCtD
Foscarnet—Thrombocytopenia—Sorafenib—liver cancer	0.00324	0.00324	CcSEcCtD
Foscarnet—Blood urea increased—Epirubicin—liver cancer	0.00324	0.00324	CcSEcCtD
Foscarnet—Coordination abnormal—Doxorubicin—liver cancer	0.00323	0.00323	CcSEcCtD
Foscarnet—Neuropathy—Epirubicin—liver cancer	0.00322	0.00322	CcSEcCtD
Foscarnet—Phosphatase alkaline increased—Doxorubicin—liver cancer	0.00318	0.00318	CcSEcCtD
Foscarnet—Anorexia—Sorafenib—liver cancer	0.00316	0.00316	CcSEcCtD
Foscarnet—Cramps of lower extremities—Epirubicin—liver cancer	0.00315	0.00315	CcSEcCtD
Foscarnet—Coma—Epirubicin—liver cancer	0.00314	0.00314	CcSEcCtD
Foscarnet—Rash maculo-papular—Epirubicin—liver cancer	0.00312	0.00312	CcSEcCtD
Foscarnet—Mouth ulceration—Epirubicin—liver cancer	0.0031	0.0031	CcSEcCtD
Foscarnet—Neoplasm—Epirubicin—liver cancer	0.0031	0.0031	CcSEcCtD
Foscarnet—Melaena—Doxorubicin—liver cancer	0.0031	0.0031	CcSEcCtD
Foscarnet—Influenza like illness—Doxorubicin—liver cancer	0.00308	0.00308	CcSEcCtD
Foscarnet—Candida infection—Doxorubicin—liver cancer	0.00303	0.00303	CcSEcCtD
Foscarnet—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00302	0.00302	CcSEcCtD
Foscarnet—Blood urea increased—Doxorubicin—liver cancer	0.003	0.003	CcSEcCtD
Foscarnet—Neuropathy—Doxorubicin—liver cancer	0.00298	0.00298	CcSEcCtD
Foscarnet—Sepsis—Epirubicin—liver cancer	0.00298	0.00298	CcSEcCtD
Foscarnet—Dyspnoea—Sorafenib—liver cancer	0.00295	0.00295	CcSEcCtD
Foscarnet—Lymphadenopathy—Epirubicin—liver cancer	0.00292	0.00292	CcSEcCtD
Foscarnet—Cramps of lower extremities—Doxorubicin—liver cancer	0.00292	0.00292	CcSEcCtD
Foscarnet—Dyspepsia—Sorafenib—liver cancer	0.00292	0.00292	CcSEcCtD
Foscarnet—Coma—Doxorubicin—liver cancer	0.0029	0.0029	CcSEcCtD
Foscarnet—Rash maculo-papular—Doxorubicin—liver cancer	0.00289	0.00289	CcSEcCtD
Foscarnet—Decreased appetite—Sorafenib—liver cancer	0.00288	0.00288	CcSEcCtD
Foscarnet—Mouth ulceration—Doxorubicin—liver cancer	0.00287	0.00287	CcSEcCtD
Foscarnet—Neoplasm—Doxorubicin—liver cancer	0.00287	0.00287	CcSEcCtD
Foscarnet—Blood alkaline phosphatase increased—Epirubicin—liver cancer	0.00286	0.00286	CcSEcCtD
Foscarnet—Fatigue—Sorafenib—liver cancer	0.00286	0.00286	CcSEcCtD
Foscarnet—Constipation—Sorafenib—liver cancer	0.00283	0.00283	CcSEcCtD
Foscarnet—Pain—Sorafenib—liver cancer	0.00283	0.00283	CcSEcCtD
Foscarnet—Eye pain—Epirubicin—liver cancer	0.00276	0.00276	CcSEcCtD
Foscarnet—Sepsis—Doxorubicin—liver cancer	0.00276	0.00276	CcSEcCtD
Foscarnet—Gastrointestinal pain—Sorafenib—liver cancer	0.00271	0.00271	CcSEcCtD
Foscarnet—Lymphadenopathy—Doxorubicin—liver cancer	0.0027	0.0027	CcSEcCtD
Foscarnet—Renal failure acute—Epirubicin—liver cancer	0.0027	0.0027	CcSEcCtD
Foscarnet—Blood alkaline phosphatase increased—Doxorubicin—liver cancer	0.00265	0.00265	CcSEcCtD
Foscarnet—Abdominal pain—Sorafenib—liver cancer	0.00262	0.00262	CcSEcCtD
Foscarnet—Body temperature increased—Sorafenib—liver cancer	0.00262	0.00262	CcSEcCtD
Foscarnet—Renal impairment—Epirubicin—liver cancer	0.00262	0.00262	CcSEcCtD
Foscarnet—Dermatitis bullous—Epirubicin—liver cancer	0.00261	0.00261	CcSEcCtD
Foscarnet—Eye pain—Doxorubicin—liver cancer	0.00255	0.00255	CcSEcCtD
Foscarnet—Hyponatraemia—Epirubicin—liver cancer	0.0025	0.0025	CcSEcCtD
Foscarnet—Renal failure acute—Doxorubicin—liver cancer	0.0025	0.0025	CcSEcCtD
Foscarnet—Renal impairment—Doxorubicin—liver cancer	0.00242	0.00242	CcSEcCtD
Foscarnet—Dermatitis bullous—Doxorubicin—liver cancer	0.00241	0.00241	CcSEcCtD
Foscarnet—Face oedema—Epirubicin—liver cancer	0.0024	0.0024	CcSEcCtD
Foscarnet—Asthenia—Sorafenib—liver cancer	0.00238	0.00238	CcSEcCtD
Foscarnet—Cardiac arrest—Epirubicin—liver cancer	0.00237	0.00237	CcSEcCtD
Foscarnet—Pruritus—Sorafenib—liver cancer	0.00234	0.00234	CcSEcCtD
Foscarnet—Ataxia—Epirubicin—liver cancer	0.00234	0.00234	CcSEcCtD
Foscarnet—Blood creatinine increased—Epirubicin—liver cancer	0.00233	0.00233	CcSEcCtD
Foscarnet—Dehydration—Epirubicin—liver cancer	0.00232	0.00232	CcSEcCtD
Foscarnet—Hyponatraemia—Doxorubicin—liver cancer	0.00231	0.00231	CcSEcCtD
Foscarnet—Hypokalaemia—Epirubicin—liver cancer	0.00227	0.00227	CcSEcCtD
Foscarnet—Diarrhoea—Sorafenib—liver cancer	0.00227	0.00227	CcSEcCtD
Foscarnet—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.00224	0.00224	CcSEcCtD
Foscarnet—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.00224	0.00224	CcSEcCtD
Foscarnet—Face oedema—Doxorubicin—liver cancer	0.00222	0.00222	CcSEcCtD
Foscarnet—Muscular weakness—Epirubicin—liver cancer	0.0022	0.0022	CcSEcCtD
Foscarnet—Alanine aminotransferase increased—Epirubicin—liver cancer	0.0022	0.0022	CcSEcCtD
Foscarnet—Cardiac arrest—Doxorubicin—liver cancer	0.00219	0.00219	CcSEcCtD
Foscarnet—Dizziness—Sorafenib—liver cancer	0.00219	0.00219	CcSEcCtD
Foscarnet—Ataxia—Doxorubicin—liver cancer	0.00217	0.00217	CcSEcCtD
Foscarnet—Blood creatinine increased—Doxorubicin—liver cancer	0.00216	0.00216	CcSEcCtD
Foscarnet—Dysphagia—Epirubicin—liver cancer	0.00215	0.00215	CcSEcCtD
Foscarnet—Dehydration—Doxorubicin—liver cancer	0.00214	0.00214	CcSEcCtD
Foscarnet—Pancreatitis—Epirubicin—liver cancer	0.00211	0.00211	CcSEcCtD
Foscarnet—Vomiting—Sorafenib—liver cancer	0.00211	0.00211	CcSEcCtD
Foscarnet—Hypokalaemia—Doxorubicin—liver cancer	0.0021	0.0021	CcSEcCtD
Foscarnet—Rash—Sorafenib—liver cancer	0.00209	0.00209	CcSEcCtD
Foscarnet—Dermatitis—Sorafenib—liver cancer	0.00209	0.00209	CcSEcCtD
Foscarnet—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.00208	0.00208	CcSEcCtD
Foscarnet—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.00208	0.00208	CcSEcCtD
Foscarnet—Headache—Sorafenib—liver cancer	0.00208	0.00208	CcSEcCtD
Foscarnet—Pancytopenia—Epirubicin—liver cancer	0.00204	0.00204	CcSEcCtD
Foscarnet—Muscular weakness—Doxorubicin—liver cancer	0.00203	0.00203	CcSEcCtD
Foscarnet—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.00203	0.00203	CcSEcCtD
Foscarnet—Neutropenia—Epirubicin—liver cancer	0.00201	0.00201	CcSEcCtD
Foscarnet—Dysuria—Epirubicin—liver cancer	0.00201	0.00201	CcSEcCtD
Foscarnet—Dysphagia—Doxorubicin—liver cancer	0.00199	0.00199	CcSEcCtD
Foscarnet—Nausea—Sorafenib—liver cancer	0.00197	0.00197	CcSEcCtD
Foscarnet—Pancreatitis—Doxorubicin—liver cancer	0.00195	0.00195	CcSEcCtD
Foscarnet—Weight decreased—Epirubicin—liver cancer	0.00195	0.00195	CcSEcCtD
Foscarnet—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.0019	0.0019	CcSEcCtD
Foscarnet—Pancytopenia—Doxorubicin—liver cancer	0.00189	0.00189	CcSEcCtD
Foscarnet—Renal failure—Epirubicin—liver cancer	0.00189	0.00189	CcSEcCtD
Foscarnet—Neuropathy peripheral—Epirubicin—liver cancer	0.00188	0.00188	CcSEcCtD
Foscarnet—Conjunctivitis—Epirubicin—liver cancer	0.00187	0.00187	CcSEcCtD
Foscarnet—Urinary tract infection—Epirubicin—liver cancer	0.00187	0.00187	CcSEcCtD
Foscarnet—Dysuria—Doxorubicin—liver cancer	0.00186	0.00186	CcSEcCtD
Foscarnet—Neutropenia—Doxorubicin—liver cancer	0.00186	0.00186	CcSEcCtD
Foscarnet—Haematuria—Epirubicin—liver cancer	0.00183	0.00183	CcSEcCtD
Foscarnet—Weight decreased—Doxorubicin—liver cancer	0.0018	0.0018	CcSEcCtD
Foscarnet—Sinusitis—Epirubicin—liver cancer	0.0018	0.0018	CcSEcCtD
Foscarnet—Agranulocytosis—Epirubicin—liver cancer	0.00179	0.00179	CcSEcCtD
Foscarnet—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.00176	0.00176	CcSEcCtD
Foscarnet—Renal failure—Doxorubicin—liver cancer	0.00175	0.00175	CcSEcCtD
Foscarnet—Neuropathy peripheral—Doxorubicin—liver cancer	0.00174	0.00174	CcSEcCtD
Foscarnet—Rhinitis—Epirubicin—liver cancer	0.00173	0.00173	CcSEcCtD
Foscarnet—Urinary tract infection—Doxorubicin—liver cancer	0.00173	0.00173	CcSEcCtD
Foscarnet—Conjunctivitis—Doxorubicin—liver cancer	0.00173	0.00173	CcSEcCtD
Foscarnet—Hypoaesthesia—Epirubicin—liver cancer	0.00171	0.00171	CcSEcCtD
Foscarnet—Pharyngitis—Epirubicin—liver cancer	0.00171	0.00171	CcSEcCtD
Foscarnet—Haematuria—Doxorubicin—liver cancer	0.00169	0.00169	CcSEcCtD
Foscarnet—Urethral disorder—Epirubicin—liver cancer	0.00169	0.00169	CcSEcCtD
Foscarnet—Sinusitis—Doxorubicin—liver cancer	0.00167	0.00167	CcSEcCtD
Foscarnet—Agranulocytosis—Doxorubicin—liver cancer	0.00166	0.00166	CcSEcCtD
Foscarnet—Erythema multiforme—Epirubicin—liver cancer	0.00163	0.00163	CcSEcCtD
Foscarnet—Eye disorder—Epirubicin—liver cancer	0.00161	0.00161	CcSEcCtD
Foscarnet—Flushing—Epirubicin—liver cancer	0.0016	0.0016	CcSEcCtD
Foscarnet—Rhinitis—Doxorubicin—liver cancer	0.0016	0.0016	CcSEcCtD
Foscarnet—Hypoaesthesia—Doxorubicin—liver cancer	0.00159	0.00159	CcSEcCtD
Foscarnet—Pharyngitis—Doxorubicin—liver cancer	0.00158	0.00158	CcSEcCtD
Foscarnet—Urethral disorder—Doxorubicin—liver cancer	0.00156	0.00156	CcSEcCtD
Foscarnet—Chills—Epirubicin—liver cancer	0.00155	0.00155	CcSEcCtD
Foscarnet—Erythema multiforme—Doxorubicin—liver cancer	0.00151	0.00151	CcSEcCtD
Foscarnet—Eye disorder—Doxorubicin—liver cancer	0.00149	0.00149	CcSEcCtD
Foscarnet—Flushing—Doxorubicin—liver cancer	0.00148	0.00148	CcSEcCtD
Foscarnet—Flatulence—Epirubicin—liver cancer	0.00148	0.00148	CcSEcCtD
Foscarnet—Tension—Epirubicin—liver cancer	0.00147	0.00147	CcSEcCtD
Foscarnet—Nervousness—Epirubicin—liver cancer	0.00146	0.00146	CcSEcCtD
Foscarnet—Back pain—Epirubicin—liver cancer	0.00145	0.00145	CcSEcCtD
Foscarnet—Muscle spasms—Epirubicin—liver cancer	0.00144	0.00144	CcSEcCtD
Foscarnet—Chills—Doxorubicin—liver cancer	0.00143	0.00143	CcSEcCtD
Foscarnet—Ill-defined disorder—Epirubicin—liver cancer	0.00139	0.00139	CcSEcCtD
Foscarnet—Anaemia—Epirubicin—liver cancer	0.00139	0.00139	CcSEcCtD
Foscarnet—Agitation—Epirubicin—liver cancer	0.00138	0.00138	CcSEcCtD
Foscarnet—Flatulence—Doxorubicin—liver cancer	0.00137	0.00137	CcSEcCtD
Foscarnet—Tension—Doxorubicin—liver cancer	0.00136	0.00136	CcSEcCtD
Foscarnet—Malaise—Epirubicin—liver cancer	0.00135	0.00135	CcSEcCtD
Foscarnet—Nervousness—Doxorubicin—liver cancer	0.00135	0.00135	CcSEcCtD
Foscarnet—Leukopenia—Epirubicin—liver cancer	0.00134	0.00134	CcSEcCtD
Foscarnet—Back pain—Doxorubicin—liver cancer	0.00134	0.00134	CcSEcCtD
Foscarnet—Muscle spasms—Doxorubicin—liver cancer	0.00133	0.00133	CcSEcCtD
Foscarnet—Palpitations—Epirubicin—liver cancer	0.00133	0.00133	CcSEcCtD
Foscarnet—Cough—Epirubicin—liver cancer	0.00131	0.00131	CcSEcCtD
Foscarnet—Convulsion—Epirubicin—liver cancer	0.0013	0.0013	CcSEcCtD
Foscarnet—Hypertension—Epirubicin—liver cancer	0.0013	0.0013	CcSEcCtD
Foscarnet—Ill-defined disorder—Doxorubicin—liver cancer	0.00129	0.00129	CcSEcCtD
Foscarnet—Anaemia—Doxorubicin—liver cancer	0.00128	0.00128	CcSEcCtD
Foscarnet—Arthralgia—Epirubicin—liver cancer	0.00128	0.00128	CcSEcCtD
Foscarnet—Chest pain—Epirubicin—liver cancer	0.00128	0.00128	CcSEcCtD
Foscarnet—Myalgia—Epirubicin—liver cancer	0.00128	0.00128	CcSEcCtD
Foscarnet—Agitation—Doxorubicin—liver cancer	0.00128	0.00128	CcSEcCtD
Foscarnet—Anxiety—Epirubicin—liver cancer	0.00127	0.00127	CcSEcCtD
Foscarnet—Discomfort—Epirubicin—liver cancer	0.00126	0.00126	CcSEcCtD
Foscarnet—Malaise—Doxorubicin—liver cancer	0.00125	0.00125	CcSEcCtD
Foscarnet—Dry mouth—Epirubicin—liver cancer	0.00125	0.00125	CcSEcCtD
Foscarnet—Leukopenia—Doxorubicin—liver cancer	0.00124	0.00124	CcSEcCtD
Foscarnet—Confusional state—Epirubicin—liver cancer	0.00123	0.00123	CcSEcCtD
Foscarnet—Palpitations—Doxorubicin—liver cancer	0.00123	0.00123	CcSEcCtD
Foscarnet—Oedema—Epirubicin—liver cancer	0.00122	0.00122	CcSEcCtD
Foscarnet—Infection—Epirubicin—liver cancer	0.00122	0.00122	CcSEcCtD
Foscarnet—Cough—Doxorubicin—liver cancer	0.00121	0.00121	CcSEcCtD
Foscarnet—Convulsion—Doxorubicin—liver cancer	0.0012	0.0012	CcSEcCtD
Foscarnet—Thrombocytopenia—Epirubicin—liver cancer	0.0012	0.0012	CcSEcCtD
Foscarnet—Hypertension—Doxorubicin—liver cancer	0.0012	0.0012	CcSEcCtD
Foscarnet—Hyperhidrosis—Epirubicin—liver cancer	0.00118	0.00118	CcSEcCtD
Foscarnet—Arthralgia—Doxorubicin—liver cancer	0.00118	0.00118	CcSEcCtD
Foscarnet—Chest pain—Doxorubicin—liver cancer	0.00118	0.00118	CcSEcCtD
Foscarnet—Myalgia—Doxorubicin—liver cancer	0.00118	0.00118	CcSEcCtD
Foscarnet—Anxiety—Doxorubicin—liver cancer	0.00118	0.00118	CcSEcCtD
Foscarnet—Discomfort—Doxorubicin—liver cancer	0.00117	0.00117	CcSEcCtD
Foscarnet—Anorexia—Epirubicin—liver cancer	0.00117	0.00117	CcSEcCtD
Foscarnet—Dry mouth—Doxorubicin—liver cancer	0.00116	0.00116	CcSEcCtD
Foscarnet—Hypotension—Epirubicin—liver cancer	0.00114	0.00114	CcSEcCtD
Foscarnet—Confusional state—Doxorubicin—liver cancer	0.00114	0.00114	CcSEcCtD
Foscarnet—Oedema—Doxorubicin—liver cancer	0.00113	0.00113	CcSEcCtD
Foscarnet—Infection—Doxorubicin—liver cancer	0.00113	0.00113	CcSEcCtD
Foscarnet—Musculoskeletal discomfort—Epirubicin—liver cancer	0.00112	0.00112	CcSEcCtD
Foscarnet—Thrombocytopenia—Doxorubicin—liver cancer	0.00111	0.00111	CcSEcCtD
Foscarnet—Insomnia—Epirubicin—liver cancer	0.00111	0.00111	CcSEcCtD
Foscarnet—Paraesthesia—Epirubicin—liver cancer	0.0011	0.0011	CcSEcCtD
Foscarnet—Hyperhidrosis—Doxorubicin—liver cancer	0.0011	0.0011	CcSEcCtD
Foscarnet—Dyspnoea—Epirubicin—liver cancer	0.00109	0.00109	CcSEcCtD
Foscarnet—Somnolence—Epirubicin—liver cancer	0.00109	0.00109	CcSEcCtD
Foscarnet—Anorexia—Doxorubicin—liver cancer	0.00108	0.00108	CcSEcCtD
Foscarnet—Dyspepsia—Epirubicin—liver cancer	0.00108	0.00108	CcSEcCtD
Foscarnet—Decreased appetite—Epirubicin—liver cancer	0.00106	0.00106	CcSEcCtD
Foscarnet—Hypotension—Doxorubicin—liver cancer	0.00106	0.00106	CcSEcCtD
Foscarnet—Fatigue—Epirubicin—liver cancer	0.00106	0.00106	CcSEcCtD
Foscarnet—Pain—Epirubicin—liver cancer	0.00105	0.00105	CcSEcCtD
Foscarnet—Constipation—Epirubicin—liver cancer	0.00105	0.00105	CcSEcCtD
Foscarnet—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.00103	0.00103	CcSEcCtD
Foscarnet—Insomnia—Doxorubicin—liver cancer	0.00102	0.00102	CcSEcCtD
Foscarnet—Paraesthesia—Doxorubicin—liver cancer	0.00102	0.00102	CcSEcCtD
Foscarnet—Dyspnoea—Doxorubicin—liver cancer	0.00101	0.00101	CcSEcCtD
Foscarnet—Feeling abnormal—Epirubicin—liver cancer	0.00101	0.00101	CcSEcCtD
Foscarnet—Somnolence—Doxorubicin—liver cancer	0.00101	0.00101	CcSEcCtD
Foscarnet—Gastrointestinal pain—Epirubicin—liver cancer	0.001	0.001	CcSEcCtD
Foscarnet—Dyspepsia—Doxorubicin—liver cancer	0.000997	0.000997	CcSEcCtD
Foscarnet—Decreased appetite—Doxorubicin—liver cancer	0.000985	0.000985	CcSEcCtD
Foscarnet—Fatigue—Doxorubicin—liver cancer	0.000977	0.000977	CcSEcCtD
Foscarnet—Pain—Doxorubicin—liver cancer	0.000969	0.000969	CcSEcCtD
Foscarnet—Constipation—Doxorubicin—liver cancer	0.000969	0.000969	CcSEcCtD
Foscarnet—Abdominal pain—Epirubicin—liver cancer	0.000968	0.000968	CcSEcCtD
Foscarnet—Body temperature increased—Epirubicin—liver cancer	0.000968	0.000968	CcSEcCtD
Foscarnet—Feeling abnormal—Doxorubicin—liver cancer	0.000933	0.000933	CcSEcCtD
Foscarnet—Gastrointestinal pain—Doxorubicin—liver cancer	0.000926	0.000926	CcSEcCtD
Foscarnet—Body temperature increased—Doxorubicin—liver cancer	0.000895	0.000895	CcSEcCtD
Foscarnet—Abdominal pain—Doxorubicin—liver cancer	0.000895	0.000895	CcSEcCtD
Foscarnet—Asthenia—Epirubicin—liver cancer	0.000878	0.000878	CcSEcCtD
Foscarnet—Pruritus—Epirubicin—liver cancer	0.000866	0.000866	CcSEcCtD
Foscarnet—Diarrhoea—Epirubicin—liver cancer	0.000838	0.000838	CcSEcCtD
Foscarnet—Asthenia—Doxorubicin—liver cancer	0.000813	0.000813	CcSEcCtD
Foscarnet—Dizziness—Epirubicin—liver cancer	0.00081	0.00081	CcSEcCtD
Foscarnet—Pruritus—Doxorubicin—liver cancer	0.000801	0.000801	CcSEcCtD
Foscarnet—Vomiting—Epirubicin—liver cancer	0.000778	0.000778	CcSEcCtD
Foscarnet—Diarrhoea—Doxorubicin—liver cancer	0.000775	0.000775	CcSEcCtD
Foscarnet—Rash—Epirubicin—liver cancer	0.000772	0.000772	CcSEcCtD
Foscarnet—Dermatitis—Epirubicin—liver cancer	0.000771	0.000771	CcSEcCtD
Foscarnet—Headache—Epirubicin—liver cancer	0.000767	0.000767	CcSEcCtD
Foscarnet—Dizziness—Doxorubicin—liver cancer	0.000749	0.000749	CcSEcCtD
Foscarnet—Nausea—Epirubicin—liver cancer	0.000727	0.000727	CcSEcCtD
Foscarnet—Vomiting—Doxorubicin—liver cancer	0.00072	0.00072	CcSEcCtD
Foscarnet—Rash—Doxorubicin—liver cancer	0.000714	0.000714	CcSEcCtD
Foscarnet—Dermatitis—Doxorubicin—liver cancer	0.000714	0.000714	CcSEcCtD
Foscarnet—Headache—Doxorubicin—liver cancer	0.00071	0.00071	CcSEcCtD
Foscarnet—Nausea—Doxorubicin—liver cancer	0.000673	0.000673	CcSEcCtD
